Flanders KC - Search Results

1

Cell type-specific expression of transforming growth factor-beta 1 in the mouse uterus during the periimplantation period.

Tamada H, McMaster MT, Flanders KC, Andrews GK, Dey SK. Tamada H, et al. Among authors: flanders kc. Mol Endocrinol. 1990 Jul;4(7):965-72. doi: 10.1210/mend-4-7-965. Mol Endocrinol. 1990. PMID: 2284009

2

Expression of transforming growth factor-beta isoforms (beta 2 and beta 3) in the mouse uterus: analysis of the periimplantation period and effects of ovarian steroids.

Das SK, Flanders KC, Andrews GK, Dey SK. Das SK, et al. Among authors: flanders kc. Endocrinology. 1992 Jun;130(6):3459-66. doi: 10.1210/endo.130.6.1375903. Endocrinology. 1992. PMID: 1375903

3

Localization and binding of transforming growth factor-beta isoforms in mouse preimplantation embryos and in delayed and activated blastocysts.

Paria BC, Jones KL, Flanders KC, Dey SK. Paria BC, et al. Among authors: flanders kc. Dev Biol. 1992 May;151(1):91-104. doi: 10.1016/0012-1606(92)90216-4. Dev Biol. 1992. PMID: 1577201

4

Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, TGF beta 3, and TGF beta type II receptor messenger ribonucleic acid and protein and contains [125I]TGF beta 1-binding sites.

Chegini N, Zhao Y, Williams RS, Flanders KC. Chegini N, et al. Among authors: flanders kc. Endocrinology. 1994 Jul;135(1):439-49. doi: 10.1210/endo.135.1.8013382. Endocrinology. 1994. PMID: 8013382

5

Presence of transforming growth factor-beta and their selective cellular localization in human ovarian tissue of various reproductive stages.

Chegini N, Flanders KC. Chegini N, et al. Among authors: flanders kc. Endocrinology. 1992 Mar;130(3):1707-15. doi: 10.1210/endo.130.3.1537318. Endocrinology. 1992. PMID: 1537318

6

Human fallopian tube expresses transforming growth factor (TGF beta) isoforms, TGF beta type I-III receptor messenger ribonucleic acid and protein, and contains [125I]TGF beta-binding sites.

Zhao Y, Chegini N, Flanders KC. Zhao Y, et al. Among authors: flanders kc. J Clin Endocrinol Metab. 1994 Oct;79(4):1177-84. doi: 10.1210/jcem.79.4.7962292. J Clin Endocrinol Metab. 1994. PMID: 7962292

7

Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix.

Comerci JT Jr, Runowicz CD, Flanders KC, De Victoria C, Fields AL, Kadish AS, Goldberg GL. Comerci JT Jr, et al. Among authors: flanders kc. Cancer. 1996 Mar 15;77(6):1107-14. Cancer. 1996. PMID: 8635131

8

Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis.

Timme TL, Truong LD, Merz VW, Krebs T, Kadmon D, Flanders KC, Park SH, Thompson TC. Timme TL, et al. Among authors: flanders kc. Endocrinology. 1994 Mar;134(3):1039-45. doi: 10.1210/endo.134.3.8119140. Endocrinology. 1994. PMID: 8119140

9

Release of a transforming growth factor (TGF)-beta 2-related suppressor factor from postimplantation murine decidual tissue can be correlated with the detection of a subpopulation of cells containing RNA for TGF-beta 2.

Lea RG, Flanders KC, Harley CB, Manuel J, Banwatt D, Clark DA. Lea RG, et al. Among authors: flanders kc. J Immunol. 1992 Feb 1;148(3):778-87. J Immunol. 1992. PMID: 1730871

10

Differential effects of transforming growth factor beta on human prostate cancer cells in vitro.

Wilding G, Zugmeier G, Knabbe C, Flanders K, Gelmann E. Wilding G, et al. Mol Cell Endocrinol. 1989 Mar;62(1):79-87. doi: 10.1016/0303-7207(89)90115-9. Mol Cell Endocrinol. 1989. PMID: 2545487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters